HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Phillips, M. E. Articles by Rother, K. Search for Related Content PubMed Articles by Phillips, M. E. Articles by Rother, K.

Serum Complement in the Rejection of Sarcoma I Ascites Tumor Grafts¹

From the Department of Pathology, New York University School of Medicine, New York, New York

Abstract

The reactivity of sarcoma I, isoantibody, and complement (C') was studied in vitro and in vivo. C' activity was needed in the cytotoxic reaction in vitro. When inoculated into the peritoneal cavity of presensitized mice, tumor cells bound mouse -globulin and C' (_1C protein) within 2 min. Tumor growth resulted in decreasing serum C' titers. There was a positive relation between the number of tumor cells implanted, loss of C' activity and death of the recipient animals. B10D2/new line mice which possess a lytic C' system were at least 10 times more efficient in the destruction of tumor implants than B10D2/old line mice which lack C'5 activity.

It is concluded that C' participates in the rejection reaction against allografted sarcoma I tumor and that biologic functions dependent on the activity of C'5 are preeminent in the graft destruction. A second mechanism was independent of C'5 and less efficient.

Footnotes

This investigation was supported by Grants AM 08986-03 and 5R01CA-07863 from the United States Public Health Service and Grant T-404 from the American Cancer Society.

² Present address: Max-Planck-Institut fur Immunbiologie, Freiburg i. Br., Germany.

This article has been cited by other articles:

				N. R. Cooper Immune Adherence by the Fourth Component of Complement Science, July 25, 1969; 165(3891): 396 - 398. [Abstract] [PDF]

				S. Broder and F. Whitehouse Jr. lmmunologic Enhancement of Tumor Xenografts by Pepsin-Degraded Immunoglobulin Science, December 27, 1968; 162(3861): 1494 - 1495. [Abstract] [PDF]